Danaher Corporation (0R2B.L)
USD 199.8
(1.48%)
USD 199.8
(1.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.75 Billion USD | 5.2% |
| 2022 | 8.65 Billion USD | -12.62% |
| 2021 | 9.9 Billion USD | 21.3% |
| 2020 | 8.16 Billion USD | 23.28% |
| 2019 | 6.62 Billion USD | 2.89% |
| 2018 | 6.43 Billion USD | -9.12% |
| 2017 | 7.08 Billion USD | 10.72% |
| 2016 | 6.39 Billion USD | 13.23% |
| 2015 | 5.64 Billion USD | 19.69% |
| 2014 | 4.71 Billion USD | -18.86% |
| 2013 | 5.81 Billion USD | -7.43% |
| 2012 | 6.28 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.31 Billion USD | 6.62% |
| 2024 Q1 | 2.17 Billion USD | -8.03% |
| 2024 Q3 | 2.44 Billion USD | 5.35% |
| 2023 Q4 | 2.36 Billion USD | -7.69% |
| 2023 FY | 8.75 Billion USD | 1.19% |
| 2023 Q1 | 2.57 Billion USD | -2.2% |
| 2023 Q2 | 2.61 Billion USD | 1.4% |
| 2023 Q3 | 2.56 Billion USD | -1.91% |
| 2022 FY | 8.65 Billion USD | -12.62% |
| 2022 Q4 | 2.63 Billion USD | 2.53% |
| 2022 Q3 | 2.56 Billion USD | 2.11% |
| 2022 Q2 | 2.51 Billion USD | -0.67% |
| 2022 Q1 | 2.53 Billion USD | -9.18% |
| 2021 Q1 | 2.14 Billion USD | -14.03% |
| 2021 Q2 | 2.39 Billion USD | 11.52% |
| 2021 Q3 | 2.47 Billion USD | 3.47% |
| 2021 Q4 | 2.78 Billion USD | 12.69% |
| 2021 FY | 9.9 Billion USD | 21.3% |
| 2020 Q3 | 2.35 Billion USD | 34.27% |
| 2020 Q4 | 2.49 Billion USD | 6.13% |
| 2020 FY | 8.16 Billion USD | 23.28% |
| 2020 Q1 | 1.74 Billion USD | -0.28% |
| 2020 Q2 | 1.75 Billion USD | 0.23% |
| 2019 FY | 6.62 Billion USD | 2.89% |
| 2019 Q4 | 1.75 Billion USD | 5.48% |
| 2019 Q3 | 1.66 Billion USD | -0.37% |
| 2019 Q2 | 1.66 Billion USD | 2.27% |
| 2019 Q1 | 1.63 Billion USD | 123.24% |
| 2018 FY | 6.43 Billion USD | -9.12% |
| 2018 Q2 | 1.94 Billion USD | 2.56% |
| 2018 Q4 | 730.19 Million USD | -60.54% |
| 2018 Q3 | 1.85 Billion USD | -4.67% |
| 2018 Q1 | 1.89 Billion USD | 1.86% |
| 2017 Q2 | 1.79 Billion USD | 5.16% |
| 2017 Q1 | 1.71 Billion USD | -4.81% |
| 2017 FY | 7.08 Billion USD | 10.72% |
| 2017 Q4 | 1.85 Billion USD | 5.02% |
| 2017 Q3 | 1.76 Billion USD | -1.63% |
| 2016 Q2 | 1.67 Billion USD | 25.58% |
| 2016 Q1 | 1.33 Billion USD | -19.71% |
| 2016 Q3 | 1.76 Billion USD | 5.65% |
| 2016 FY | 6.39 Billion USD | 13.23% |
| 2016 Q4 | 1.79 Billion USD | 1.76% |
| 2015 FY | 5.64 Billion USD | 19.69% |
| 2015 Q4 | 1.65 Billion USD | 18.31% |
| 2015 Q3 | 1.4 Billion USD | 59.79% |
| 2015 Q2 | 876.8 Million USD | -48.82% |
| 2015 Q1 | 1.71 Billion USD | -1.52% |
| 2014 FY | 4.71 Billion USD | -18.86% |
| 2014 Q4 | 1.73 Billion USD | 12.38% |
| 2014 Q1 | 1.66 Billion USD | 0.93% |
| 2014 Q3 | 1.54 Billion USD | 4.51% |
| 2014 Q2 | 1.48 Billion USD | -10.99% |
| 2013 Q3 | 1.61 Billion USD | -2.4% |
| 2013 Q2 | 1.65 Billion USD | 21.02% |
| 2013 FY | 5.81 Billion USD | -7.43% |
| 2013 Q1 | 1.36 Billion USD | -18.86% |
| 2013 Q4 | 1.64 Billion USD | 2.26% |
| 2012 Q4 | 1.68 Billion USD | 0.0% |
| 2012 FY | 6.28 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -2267.233% |
| Accuray Incorporated | 142.61 Million USD | -6038.819% |
| Align Technology, Inc. | 2.07 Billion USD | -321.557% |
| Elevance Health Inc. | 36.23 Billion USD | 75.839% |
| AxoGen, Inc. | 149.33 Million USD | -5762.619% |
| Boston Scientific Corporation | 7.5 Billion USD | -16.64% |
| CVS Health Corporation | 40.68 Billion USD | 78.483% |
| Cardinal Health, Inc. | 5 Billion USD | -75.1% |
| Centene Corporation | 138.33 Billion USD | 93.671% |
| DaVita Inc. | 1.47 Billion USD | -493.968% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 80.732% |
| Hologic, Inc. | 1.26 Billion USD | -590.675% |
| Humana Inc. | 102.36 Billion USD | 91.447% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -701.122% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -333.116% |
| Masimo Corporation | 867 Million USD | -909.804% |
| McKesson Corporation | 8.67 Billion USD | -0.922% |
| Patterson Companies, Inc. | 1.12 Billion USD | -676.622% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -443.789% |
| ResMed Inc. | 1.36 Billion USD | -539.811% |
| Henry Schein, Inc. | 2.93 Billion USD | -198.093% |
| Teladoc Health, Inc. | 2.09 Billion USD | -318.712% |
| Universal Health Services, Inc. | 9.2 Billion USD | 4.923% |
| Veeva Systems Inc. | 1.25 Billion USD | -596.473% |
| Baxter International Inc. | 5.27 Billion USD | -66.066% |
| Becton, Dickinson and Company | 6.71 Billion USD | -30.438% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -195.507% |
| Stryker Corporation | 9.2 Billion USD | 4.93% |
| Medtronic plc | 16.12 Billion USD | 45.719% |